Acetylsalicylic acid Not Yet Recruiting Phase 0 Trials for Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT03900871Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma